Serial Number | 97900409 |
Word Mark | MEGASTRENGTH |
Filing Date | Friday, April 21, 2023 |
Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
Status Date | Monday, May 6, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Goods and Services | Acne treatment preparations in the form of sprays and creams; Creams for dermatological use; Medicinal creams for skin care; Non-medicated, therapeutic skin creams for the treatment of warts; Tissues impregnated with pharmaceutical lotions for sunburn, skin conditions, treating eczema and preventing diaper rash |
Pseudo Mark | MEGA STRENGTH |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, May 17, 2023 |
Primary Code | 005 |
First Use Anywhere Date | Tuesday, March 14, 2023 |
First Use In Commerce Date | Tuesday, March 14, 2023 |
Party Name | Aurulentus Trading LLC |
Party Type | 10 - Original Applicant |
Legal Entity Type | 16 - Limited Liability Company |
Address | WOODLAND HILLS, CA 91364 |
Event Date | Event Description |
Tuesday, April 25, 2023 | NEW APPLICATION ENTERED |
Friday, January 19, 2024 | ASSIGNED TO EXAMINER |
Wednesday, May 17, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Friday, January 19, 2024 | NON-FINAL ACTION WRITTEN |
Friday, January 19, 2024 | NON-FINAL ACTION E-MAILED |
Friday, January 19, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Monday, May 6, 2024 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
Monday, May 6, 2024 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |